Cleared Traditional

K142037 - QUANTRA

K142037 is an FDA 510(k) clearance for QUANTRA, manufactured by Hologic, Inc.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 74-day FDA review.

K142037 · Hologic, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2014
Decision
74d
Days
Class 2
Risk

K142037 is an FDA 510(k) clearance for the QUANTRA. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Hologic, Inc. (Santa Clara, US). The FDA issued a Cleared decision on October 10, 2014 after a review of 74 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Hologic, Inc. devices

FDA 510(k) Submission Details - K142037

510(k) Number K142037 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 28, 2014
Decision Date October 10, 2014
Days to Decision 74 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
33d faster than avg
Panel avg: 107d · This submission: 74d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1914
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K142037.
IQQA-BODYIMAGING SOFTWARE
K141745 · Edda Technology · Oct 2014
RAPIDRESULTS
K141881 · Ramsoft, Inc. · Oct 2014
NOVAPACS
K132853 · Novarad Corp. · Oct 2014
SURGIMAP
K141669 · Nemaris, Inc. · Sep 2014
EBM IDO VIEWER
K140399 · Ebm Technologies USA, LLC · Sep 2014
DENTAL IMAGING SOFTWARE
K141607 · Trophy · Sep 2014